Results 151 to 160 of about 149,769 (206)

Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies

European Journal of Clinical Investigation, Volume 56, Issue 10, October 2026.
COPD is a heterogeneous disease driven by overlapping neutrophilic and eosinophilic inflammatory pathways. This review highlights the shift from symptom‐based treatment toward phenotype‐ and biomarker‐directed care. Blood eosinophils, FeNO, and IgE predict corticosteroid responsiveness and identify candidates for biologic therapy.
Sasha Raman, Sreya Rahman, Francesca Polverino, Muhammad Adrish   +3 more
wiley   +1 more source

Long-acting muscarinic antagonists for the treatment of asthma in children-a new kid in town. [PDF]

Allergo J Int, 2018
Hamelmann E.
europepmc   +1 more source

Characterizing short‐term linear and nonlinear heart rate variability in typically developing children and adolescents

Physiological Reports, Volume 14, Issue 19, October 2026.
Nonlinear heart rate variability differed by age and sex in typically developing youth. Nonlinear measures were associated with parasympathetic indices. Figure generated in Biorender. Abstract Linear heart rate variability (HRV) quantifies heart rate (HR) changes due to stochastic processes while nonlinear HRV captures the complexity of the HR ...
Alexs A. Matias, Michele N. D'Agata, Krista M. Szymanski, Evan C. Ciecko, Melissa A. Witman   +4 more
wiley   +1 more source

Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma. [PDF]

Allergy Asthma Immunol Res, 2017
Aalbers R, Park HS.
europepmc   +1 more source

From diarrhoea to duodenal stricture: Contrast computed tomography and portal vein gas enhance disease staging

Equine Veterinary Education, Volume 38, Issue 10, Page 516-518, October 2026.
C. A. McKinney‐Aguirre, N. S. Browne
wiley   +1 more source

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same? [PDF]

Tuberc Respir Dis (Seoul), 2018
Miravitlles M, Baek S, Vithlani V, Lad R.   +3 more
europepmc   +1 more source

Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma? [PDF]

Eur Respir Rev, 2016
Busse WW, Dahl R, Jenkins C, Cruz AA.
europepmc   +1 more source

Synthesis and evaluation of 4,6-disubstituted pyrimidines as CNS penetrant pan-muscarinic antagonists with a novel chemotype. [PDF]

Bioorg Med Chem Lett, 2017
Bender AM, Weiner RL, Luscombe VB, Cho HP, Niswender CM, Engers DW, Bridges TM, Conn PJ, Lindsley CW.   +8 more
europepmc   +1 more source

Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and Beyond. [PDF]

JAMA Psychiatry
Keshavan MS, Nasrallah HA, Abi-Dargham A, Grace AA, Javitt DC, Lewis DA, Marder SR, Meyer JM, Murray RM, Öngür D, Stahl SM, Tandon R.   +11 more
europepmc   +1 more source